AAT-13823-36173
4 vaccinations
1 coded response
17 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 148 / NY
- Registered
- 2022-04-27
- Relationship
- Child or adolescent in my care
- Guardian
- AKK-12597-84638
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-05
Dose 1 — Pfizer-BioNTech
-
2021-11-29
Dose 2 — Pfizer-BioNTech
-
2022-04-27
Registered in v-safe
- 2022-06-01
-
2022-06-15
Dose 3 — Pfizer-BioNTech
- 2022-09-16
-
2022-11-09
Dose 4 — Moderna
- 2022-11-09
- 2022-11-10
- 2022-11-11
- 2022-11-12
- 2022-11-13
- 2022-11-14
- 2022-11-15
- 2022-11-16
- 2022-11-23
-
2022-11-30
Survey response — day 21, dose 4, dependentMedDRA: Respiratory syncytial virus infection — Feeling: GoodFree text: Mild RSVMedDRA releases: 2024-11 · check-in free text available
- 2022-12-07
- 2022-12-14
- 2022-12-21
- 2023-02-08
- 2023-05-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-05 | Pfizer-BioNTech | No |
| 2 | 2021-11-29 | Pfizer-BioNTech | No |
| 3 | 2022-06-15 | Pfizer-BioNTech | No |
| 4 | 2022-11-09 | Moderna | No |
Free text
Release 12 — day 21, dose 4, dependent
Symptoms: Mild RSV
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Respiratory syncytial virus infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release